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PERSPECTIVES
Global Mental Health: From Science to Action
Vikram Patel, MD, PhD
This article charts the historical development of the discipline of global mental health, whose
goal is to improve access to mental health care and reduce inequalities in mental health outcomes
between and within nations. The article begins with an overview of the contribution of four scientific
foundations toward the discipline’s core agenda: to scale up services for people with mental disorders
and to promote their human rights. Next, the article highlights four recent, key events that are
indicative of the actions shaping the discipline: the Mental Health Gap Action Programme to
synthesize evidence on what treatments are effective for a range of mental disorders; the evidence on
task shifting to nonspecialist health workers to deliver these treatments; the Movement for Global
Mental Health’s efforts to build a common platform for professionals and civil society to advocate
for their shared goal; and the Grand Challenges in Global Mental Health, which has identified the
research priorities that, within the next decade, can lead to substantial improvements in the lives of
people living with mental disorders. The article ends by examining the major challenges for the field,
and the opportunities for addressing them in the future. (HARV REV PSYCHIATRY 2012;20:6–12.)
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INTRODUCTION: THE SCIENCE
The emergence of the discipline of global mental health can
be traced to a long and distinguished history of interdisci-
plinary research going back at least as far as Kraepelin’s
1904 investigation in Java of the cross-cultural epidemiol-
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ogy of severe mental disorders.1 The original goal of this re-
search effort was to determine the relevance of a biomedical,
psychiatric perspective on mental disorders—one largely
derived from observations in the cultures of Europe and
North America—to other cultures and societies around the
world. This effort became more intense in the 1970s, fol-
lowing the arrival of the phenomenologically based psy-
chiatric classifications, which emphasized psychopathology,
rather than psychoanalytical causal interpretations, as the
primary basis for taxonomy and clinical decision making.
Two strands of research examined the application of these
classifications, one taking a dominantly relativist view of
mental disorders and the other assuming a universalist
perspective. The former was a derivative of a strong re-
search endeavor to document indigenous systems of knowl-
edge that have described mental disorders from time im-
memorial. Over time, it came to be clear that each approach
had strengths and weaknesses, and that integrating their
methodological contributions was essential for the develop-
ment of a “new cross-cultural psychiatry” or a culturally
sensitive psychiatry.2,3 The consensus that emerged from
this integrative approach was that despite the important
contextual influences on how mental disorders were ex-
perienced, explained, and acted upon, these health condi-
tions affected people in all cultures and societies, and were
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neither a figment of the “Western” imagination nor a colonial
export.
Having established that mental disorders were “real”
causes of human suffering, four major contributions played
critically important roles in consolidating the evidence that
forms the foundation of the discipline of global mental
health.4 First was the evidence demonstrating the strong
associations between mental disorders and social disadvan-
tage, especially poverty, violence, gender disadvantage, and
conflicts and disasters. This evidence was first synthesized
in a 1995 report, World Mental Health.5 The evidence base
was updated in 2009 for the Commission for Social De-
terminants in Health6 of the World Health Organization
(WHO) and in 2010 by a systematic review on poverty and
common mental disorders.7 Second was the development
of the DALY (disability-adjusted life year), a metric that
reflects the contribution of a disorder or disease to dis-
ability and mortality, and the large and growing body of
cross-national epidemiological research that revealed the
staggering impact of mental disorders. These contributions
demonstrated that mental disorders—notably, conditions
such as depression, alcohol use, and schizophrenia—were
leading causes of the global burden of disease and that this
burden resulted from their high prevalence, chronic or re-
lapsing course, onset early in life, and impact on disabil-
ity and, to a lesser extent, mortality.8 A related body of
evidence demonstrated the intimate interrelationships be-
tween physical health problems and mental disorders, each
fueling the other and producing worse outcomes for both,
leading to the slogan “no health without mental health.”9
Third was the body of evidence, much of it published
in the past decade, demonstrating the efficacy and cost-
effectiveness of a range of pharmacological and psychoso-
cial treatments for mental disorders in low- and middle-
income countries (LAMICs).10 Fourth and last was the evi-
dence demonstrating the systematic denial and abuse of the
basic right to a life with dignity for people with mental disor-
ders worldwide—in particular, those living with psychoses
or mental disabilities, whether residing in hospitals or liv-
ing in their own communities.11,12 This prompted Kleinman,
an icon of global mental health, to declare this last situation
as a “failure of humanity.”13
Despite this robust evidence base, the reality for most
people affected by mental disorders has been an uncaring
health system that does little to respond to their needs,
leading to estimates that up to three of four affected per-
sons in LAMICs do not receive the treatments known to
work.14 In sub-Saharan Africa this “treatment gap” can ex-
ceed 90%, even for schizophrenia and other psychoses, the
most severe and disabling of mental disorders.15 This gap is
hardly surprising, given that LAMICs command less than
20% of global mental health resources.16 This evidence was
the basis for the Lancet series on global mental health, a
series of six articles published in September 2007, which
sought to focus the global health spotlight on mental dis-
orders. The Lancet, the leading journal for global health,
had been championing neglected and priority global health
issues for several years through various series of articles.
These series, typically organized by global experts in the
field, have provided space for synthesizing evidence from
diverse sources and an opportunity to use this evidence to
call for appropriate, responsive action. The Lancet’s series
on global mental health was pivotal in the development of
the discipline.
That series was led by three editors (two academics from
London-based institutions, including the author of this ar-
ticle, and one from the WHO), with robust support from the
Lancet’s editor-in-chief and an interdisciplinary, global aca-
demic advisory board. The series focused squarely on the
needs and resources for addressing mental disorders (not
“mental health” in its broadest sense) in LAMICs. Five arti-
cles documented the burden and impact of mental disorders,
the evidence on the effective treatments for mental disor-
ders, the unmet needs for evidence-based care in LAMICs,
the grave shortages and iniquitous distribution of global
mental health resources, and the barriers to scaling up ser-
vices for mental disorders.9,10,16−19 Based on this evidence,
the series’ last article was a call to action to scale up the
coverage of services for people with mental disorders.20 The
authors recommended that this scaling-up process needed
to be informed by two principles: scientific evidence on cost-
effective treatments and a respect for the human rights of
people affected by mental disorders. The authors also called
for greater investments in building the research evidence to
guide this scaling-up process.
I will now briefly review four recent events that have
galvanized the discipline of global mental health and that
illustrate the variety of actions needed for the discipline to
flourish and, one hopes, to achieve its ambitious goals: syn-
thesizing the global evidence on what treatments should be
scaled up through primary care; building the evidence base
on how these treatments should be delivered in resource-
constrained settings; establishing a social movement to mo-
bilize resources and political will; and setting the priority
agenda for research. In the final section, I will consider three
key barriers that the field will need to address in the years
ahead and strategies on how that might be done.
THE ACTIONS
Synthesizing Evidence on What Should Be Scaled Up:
mhGAP
The Mental Health Gap Action Programme (mhGAP) is
the WHO’s flagship program on mental health. It was
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launched in 2008 with the mandate of producing evidence-
based guidelines for managing mental, neurological, and
substance use disorders by nonspecialist health workers
in routine health care settings. Eight groups of “priority
conditions” were identified using an established set of cri-
teria, including burden and impact. These conditions were
depression, schizophrenia, and other psychotic disorders
(including bipolar disorder); suicide prevention; epilepsy;
dementia; disorders due to use of alcohol and illicit drugs;
and mental disorders in children. A two-year process—led
by a core team in WHO, supported by an international
Guidelines Development Group—produced guidelines
using the Grading of Recommendations Assessment, De-
velopment and Evaluation (GRADE) methodology.21 The
guidelines were packaged together as a 100-page manual;22
the mhGAP–Intervention Guide (mhGAP-IG) was launched
in October 2010 by the WHO director-general. These guide-
lines are a uniquely valuable resource in global mental
health, as they serve to address the central question faced
by global health practitioners: what can be done in routine
health care, by nonspecialist health workers, to treat
mental disorders. Moreover, in addressing a range of health
conditions that have shared primary origins in the brain,
the guidelines also break down the traditional biomedical
walls separating neurology, psychiatry, and addiction. These
divisions of health care, which emanate from top-down, ex-
pensive health systems, are neither affordable nor practical
for most populations globally. The guidelines also cover all
aspects of care, from specific pharmacological, psychological,
and social interventions, to general principles of care, in-
cluding those related to autonomy and dignity. The mhGAP
provides a robust foundation for scaling up by answering the
key question of what should be scaled up. Now, the primary
research challenge is addressing the how question—that is,
how these treatments can be scaled up. The mhGAP-IG is
currently being evaluated in Ethiopia, Jordan, Nigeria, and
Panama as part of mhGAP implementation. Concurrently,
the United Kingdom’s Department for International Devel-
opment has funded the Programme for Improving Mental
Health Care (PRIME), a six-year research consortium led
by the University of Cape Town, to adapt and evaluate the
mhGAP-IG in primary health care settings in Ethiopia,
India, Nepal, South Africa, and Uganda.
Building Evidence on How Scaling Up Can Be Achieved
Through Task Shifting
Only recently has it come to be accepted that the scope of
“translational medicine” extends beyond its traditional fo-
cus on translating basic science discoveries into “products”
with a potential to improve health, and that it requires,
in addition, translating the knowledge of efficacious treat-
ments into improved clinical practice and, ultimately, into
improved health outcomes in entire populations. This pro-
cess of translation will potentially encounter at least three
roadblocks: between basic science and “first in man” stud-
ies; between efficacy and effectiveness trials; and between
the formulation of clinical guidelines and the delivery in
routine clinical practice.23 Implementation research is often
considered to be concerned with the second and, in particu-
lar, the third of these roadblocks. The roadblocks lie on the
path between knowing what works (as synthesized in the
mhGAP-IG) and how it will be delivered “to scale”—that is,
to entire populations. The single largest barrier to scaling up
efficacious treatments for mental disorders is the enormous
scarcity and inequality in the distribution of skilled human
resources in low-resource settings.16 In simple numerical
terms, one need only compare the number of psychiatrists
in the United States (estimated as 50,000 for a population
of roughly 300 million) with the number in India (estimated
as 4000 for a population of well over a billion) to provide
a vivid illustration of this iniquity. This vast disparity in
relative numbers hides equally massive within-country dis-
parities since the majority of psychiatrists in India work in
urban areas, where only a minority of the population lives.
To close the treatment gap, mental health care must
therefore be delegated to nonspecialist health workers who
are trained to deliver interventions for specific mental dis-
orders. Task shifting, which refers to the strategy of ratio-
nal redistribution of tasks among health workforce teams,
has become a popular method for addressing shortages of
specialist health resources. When appropriate, highly qual-
ified health workers share specific tasks with health work-
ers having less training and fewer qualifications in order to
make more efficient use of the available human resources. It
is not surprising, then, that the leading research questions
emerging from a priority-setting exercise (in the context of
scaling up) were to develop and evaluate mental health in-
terventions for delivery by nonspecialist health workers and
to determine how such task-shifted interventions could be
integrated within routine health care delivery systems.24 It
is heartening to observe that several leading research fun-
ders have redoubled their commitment to supporting such
implementation research to reduce the treatment gap. An
excellent example of such a commitment is the recent Na-
tional Institute of Mental Health (U.S.) initiative to support
the establishment of “hubs” to promote research to reduce
the treatment gap in LAMICs.
The evidence base for task shifting in mental health care
in LAMICs, though comparatively young, is growing and
is consistent in its findings. We now know that lay people
or community health workers can be trained to deliver
psychological and psychosocial interventions for people
with depressive and anxiety disorders, schizophrenia, and
dementia in a diverse range of LAMICs.25−29,30 A critical
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element of these task-shifting interventions—and a signifi-
cant departure from earlier efforts to improve primary men-
tal health care—is that the role of mental health specialists
extends well beyond the training phase; they provide con-
tinuing supervision, quality assurance, and support to the
nonspecialist health workers.31 This model is thus similar to
“collaborative” models of care, which are the most effective
delivery systems for depression management in primary
care in developed countries.32 It may well be more appro-
priate to refer to such collaborative models of care as “task
sharing” rather than “task shifting.” The most recent inves-
tigation of task sharing is the MANAS trial. That trial—the
largest trial in psychiatry in LAMICs—demonstrated the
effectiveness of trained lay counselors in improving recov-
ery rates in patients with anxiety or depressive disorders
at primary health care centers.33 By demonstrating the
role of lay people in providing mental health care, trials
like MANAS throw open the door of opportunity for task
sharing to virtually anyone in the population.
Building a Coalition for Mental Health: The Movement
for Global Mental Health
The Movement for Global Mental Health (Movement),
launched in October 2008, is a coalition of individuals
and institutions committed to collective actions that aim
both to close the treatment gap for people living with
mental disorders worldwide and to promote their human
rights—focusing on those populations with the largest
gaps.34 A key goal is to provide the diverse range of parties
involved—mental health professionals of all dispositions,
civil society activists, global health advocates, and people
affected by mental disorders—an opportunity to cast
aside their differences, to stand shoulder to shoulder,
and to advocate for a shared cause. Since its inception,
the Movement has grown to over 1700 individual and
94 institutional members (as of 10 July 2011) from over
100 countries around the world, with strong participation
of women, people from LAMICs, and people affected by
mental disorders. The Movement seeks to build a coalition
whose diverse members not only share a common goal but
can use the Movement both to support their own activi-
ties and to strengthen the Movement itself. The website
(www.globalmentalhealth.org) plays a central role as a “vir-
tual headquarters.” Any individual and any institution that
share these goals can become a member through the site,
which also includes a wide range of resources submitted
by members for sharing, such as packages of care, human
rights stories, and advocacy articles. In early 2009, a profile
of the Movement was added to the social-networking site
Facebook, expanding the Movement’s online presence. In
2010, the Movement decided that it needed a voluntary
secretariat to facilitate its growth; through a participatory
process, the Centre for International Mental Health of the
University of Melbourne was selected as the secretariat
for the first three-year term (2011–14). Major examples of
the Movement’s activities include hosting biennial summits
as a platform for members to meet face-to-face and to
share their experiences and initiate new collaborations (the
second summit took place in Cape Town in October 2011);
developing a Capacity Building Atlas for Global Mental
Health (http://www.globalmentalhealth.org/cb atlas.html),
which provides information on relevant training programs;
partnering with the Lancet, an institutional member of the
Movement, to prepare and launch the series of six articles
on global mental health published in October 2011;35 and
partnering with the World Federation for Mental Health,
another institutional partner, in support of its Great Push
for Mental Health global campaign.36
Addressing the “Grand Challenges in Global Mental
Health”
A “grand challenge” in the context of global health is a
specific barrier that, if addressed, would help to improve
the lives of those affected by a health problem. The goal
of identifying these challenges is to develop interventions
that, if successfully implemented, would have a high like-
lihood of feasibility for scaling up and having a significant
impact. The Grand Challenges in Global Mental Health Ini-
tiative (www.grandchallengesgmh.nimh.nih.gov), which fol-
lows two high-profile Grand Challenge initiatives (the first
focused on infectious diseases, and the second on cardiovas-
cular and metabolic disease), is led by a consortium com-
prising the Global Alliance for Chronic Diseases, National
Institute of Mental Health, and Wellcome Trust. The initia-
tive used a Delphi methodology, with over 400 global experts,
to prioritize 25 “challenges.”37
Unsurprisingly, the leading five challenges—ranked ac-
cording to their potential for reduction of disease burden,
impact on equity, immediacy of impact, and feasibility—
focused on improving access to evidence-based care and
building the mental health skills of all health care person-
nel. Other challenges focused on improving our understand-
ing of the root causes of, and protective factors for, mental
disorders and on advancing knowledge that can lead to more
effective prevention and early interventions.
Four broad themes were evident: (1) research needs to
incorporate a life-course approach acknowledging the devel-
opmental origins of many mental disorders; (2) suffering re-
lated to mental disorders extends to families and communi-
ties, with the consequence that health system–wide changes
are essential, along with efforts to reduce social exclusion
and discrimination; (3) all care and treatment interventions
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must be grounded in evidence; and (4) mental health and
environmental exposures, such as extreme poverty and war,
are closely related.
As is evident from this initiative, both “discovery” and
“delivery” research is needed to significantly reduce the bur-
den of mental disorders worldwide.37 In the few months
since the publication of the findings, two funders (Grand
Challenges Canada and the Task Force for Neurosciences,
Department of Biotechnology, [government of] India) have
already announced calls for applications for research target-
ing these challenges.
THE FUTURE
Global mental health is the discipline that seeks to address
one of the most neglected global health issues of our time.
It is also one of the most exciting and dynamic disciplines
of global health, with a growing legion of advocates, donors,
commitments, and initiatives. While we must celebrate this
“coming of age,” the field still has a long road ahead—one
strewn with challenges. Three major barriers loom ahead
and will need to be addressed head-on.
The first barrier is the pervasive stigma against those
who are living with mental disorders—which affect virtu-
ally every domain of their lives. Included here is the low po-
litical will of countries to prioritize and act on the evidence
base of global mental health. Although some countries, such
as Brazil and India, have shown some capacity to set their
own health agendas independent of foreign donors and are
now putting greater resources behind mental health,18 these
allocations remain insufficient when compared to the scale
of unmet needs. In countries whose health policies remain
in the grips of international donors, the ability to prioritize
mental health is hindered by the blinkered views of North-
ern donors, who generally harbor misguided views that men-
tal health is not a priority for poor people or less-resourced
countries. Activists from the Movement for Global Mental
Health recently called for a special session of the UN Gen-
eral Assembly or for a summit on mental health38—which
may prove to be a fruitful way of galvanizing the global com-
munity, from donors to governments, to act on the evidence
that we already possess.
The second major barrier is the mental health commu-
nity’s relatively weak engagement with the agenda of global
mental health. Psychiatry and other mental health profes-
sions have a key role to play in scaling up for several rea-
sons: specialists need to provide the supervision needed for
the successful implementation of task sharing; psychiatrists
are often key decision makers for mental health policies and
programs; and the leadership of psychiatrists is needed to
encourage the broader profession to work in solidarity with
other mental health stakeholders. A recent survey of leaders
in psychiatry in nearly 60 countries showed their support for
three strategies for reducing the treatment gap: increasing
the numbers of psychiatrists and other mental health pro-
fessionals; increasing the involvement of a range of appro-
priately trained nonspecialist providers; and increasing the
active involvement of people affected by mental disorders.39
In the new world of global mental health, where an increas-
ing proportion of front-line mental health care is shared
with nonspecialist health workers, unique demands will be
placed on psychiatrists and other mental health practition-
ers. They will need to be proficient in skills for training
and supervising nonspecialist health workers; be engaged
in monitoring and evaluation for quality assurance of men-
tal health care programs; acquire the management skills
essential for leading teams of health workers; and serve as
advocates for the human rights of people with mental disor-
ders. Put simply, the models used in comparatively better-
resourced settings—with their armies of mental health pro-
fessionals (which, ironically, still never seem sufficient to
meet local needs)—have no chance of addressing the huge
treatment gaps in LAMICs.40
The final barrier relates to the imperfections in our cur-
rent state of knowledge about the nature of mental disor-
ders and the armamentarium of effective treatments. The
bottom line is that, when compared to what we know about
most other chronic and noncommunicable diseases, we are
far from understanding either the etiology of the perplexing
disorders that affect mental health and also far from pos-
sessing treatments that are equally effective. It is clear that
we need more investment in research into the nature and
treatment of mental disorders, as highlighted by the Grand
Challenges, and that this research must be carried out in
both high-income countries and in LAMICs. Population-
based studies should help us to characterize the phenotypes
of mental disorders, as well as the variations in the distri-
bution of disorders between and within diverse populations.
The World Mental Health Surveys and the 10/66 Dementia
Research Group program are two examples of such global,
cross-national initiatives to study the prevalence and im-
pact of mental disorders, along with health systems’ re-
sponses to them. We need similar initiatives in areas not
covered so far—notably, psychoses and child mental disor-
ders. We also need to increase the pool of efficacious, safe,
and acceptable treatments for mental disorders. Integrating
strategies used in traditional systems of health care in non-
Western cultures may be one option, as has been illustrated
by mindfulness-based techniques (now adapted for use in
cognitive and behavioral therapies). No systematic research
initiatives have been undertaken, however, to map and
evaluate the treatments, pharmacological or psychosocial,
used by African, Asian, or native American cultures from
time immemorial for managing mental disorders. Is the
mental health equivalent of arteminisin awaiting discovery?
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Where the field of global mental health will be ten years
from now is difficult to predict, but the portents are promis-
ing. The developments in recent years have renewed the
passion and commitment of advocates—academics, practi-
tioners, and those who live with mental disorders and their
families—to promote the cause of global mental health and
to ensure that it remains in the foreground of global health
efforts.
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